Adla Tessier
Internal Medicine · San Diego, CANPI 1013915594
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Echosens North America, Inc. at 46.9% of the total. Reporting peaked in 2021 at $3,074 and has fallen 72.0% since, to $862 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $73.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Echosens North America, Inc.$3K
- Gilead$918
- Madrigal Pharmaceuticals$445
- AbbVie$442
- Valeritas, Inc.$282
- Lilly USA, LLC$174
- plus $1K from 21 others
What the payments were for
- Speaking & faculty fees$3,03047%
- Travel & lodging$50%
- Food & beverage$3,43153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Echosens North America, Inc. | 2 | $3,030 |
| Gilead | 15 | $918 |
| Madrigal Pharmaceuticals | 12 | $445 |
| AbbVie | 18 | $442 |
| Valeritas, Inc. | 6 | $282 |
| Lilly USA, LLC | 7 | $174 |
| Novo Nordisk | 3 | $158 |
| Edwards Lifesciences | 1 | $150 |
| Eisai Inc. | 1 | $123 |
| AstraZeneca | 1 | $119 |
| Novartis | 1 | $114 |
| Amgen | 1 | $78 |
| Biocompatibles, Inc. | 1 | $68 |
| Dexcom, Inc. | 3 | $62 |
| Intercept Pharmaceuticals, Inc. | 3 | $59 |
| Merck | 2 | $34 |
| Orphalan Inc | 1 | $33 |
| Abbott | 1 | $25 |
| Dynavax Technologies Corporation | 1 | $25 |
| Corcept Therapeutics | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Mannkind Corporation | 1 | $17 |
| Mirum Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Pfizer | 1 | $13 |
| Zealand Pharma US, Inc. | 1 | $12 |
| Phadia US Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,466 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 31 | $38,732 |
| OzempicSemaglutide | 31 | $32,641 |
| Entecavir | 15 | $2,494 |
| Humalog Kwikpen U-100Insulin Lispro | 13 | $1,894 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,277 |
| Levothyroxine Sodium | 12 | $236 |
| Metformin Hcl | 22 | $158 |
| Atorvastatin Calcium | 20 | $106 |
| Lisinopril | 17 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $158 | $32,64131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Diego
- Hatim HusainSan Diego$2M
- Steven EdelmanSan Diego$863K
- Christian RamersSan Diego$675K
- Adam ZweigSan Diego$421K
- James BreitmeyerSan Diego$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Teck LingPalo Alto$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.